A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough

NCT03979638 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
68
Enrollment
INDUSTRY
Sponsor class

Stopped Trial was terminated due to the impact of the COVID-19 on trial activities. 68 patients with refractory chronic cough were enrolled with 52 completing treatment

Conditions

Interventions

Sponsor

Bellus Health Inc. - a GSK company